EFFICACY AND SAFETY OF ELTROMBOPAG FOR THE TREATMENT OF THROMBOCYTOPENIA OF LOW AND INT-1 RISK MDS: PRELIMINARY RESULTS OF A PROSPECTIVE, RANDOMIZED, SINGLE-BLIND PLACEBO-CONTROLLED TRIAL

被引:0
|
作者
Oliva, E. [1 ]
Latagliata, R. [2 ]
Santini, V. [3 ]
Palumbo, G. [4 ]
Poloni, A. [5 ]
Cortelezzi, A. [6 ]
Cufari, P. [7 ]
Roda, F. [7 ]
Marino, A. [7 ]
Denisi, G. [1 ]
Leoni, P. [5 ]
Di Raimondo, F. [4 ]
Alimena, G. [2 ]
Nobile, F. [7 ]
机构
[1] Azienda Osped BMM, Reggio Di Calabria, Italy
[2] Sapienza Univ Rome, Dept Cellular Biotechnol & Hematol, Rome, Italy
[3] Univ Florence, AOU Careggi, Florence, Italy
[4] Azienda Osped Univ Policlin Vittorio Emanuele, Hematol Unit, Catania, Italy
[5] Univ Politecn Marche, Hematol Unit, Ancona, Italy
[6] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy
[7] Azienda Osped BMM, Hematol Unit, Reggio Di Calabria, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1138
引用
收藏
页码:470 / 470
页数:1
相关论文
共 50 条
  • [1] Efficacy and Safety of Eltrombopag for the Treatment of Thrombocytopenia of Low and Intermediate-1 IPSS Risk Myelodysplastic Syndromes: Interim Analysis of a Prospective, Randomized, Single-Blind, Placebo-Controlled Trial (EQoL-MDS)
    Oliva, Esther Natalie
    Santini, Valeria
    Zini, Gina
    Palumbo, Giuseppe A.
    Poloni, Antonella
    Cortelezzi, Agostino
    Voso, Maria Teresa
    Molteni, Alfredo
    Sanpaolo, Grazia
    Marino, Antonio
    Roda, Filippo
    Alati, Caterina
    Ronco, Francesca
    Di Raimondo, Francesco
    Leoni, Pietro
    Alimena, Giuliana
    Finotto, Silvia
    Latagliata, Roberto
    Nobile, Francesco
    [J]. BLOOD, 2012, 120 (21)
  • [2] Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial
    Oliva, Esther N.
    Alati, Caterina
    Santini, Valeria
    Poloni, Antonella
    Molteni, Alfredo
    Niscola, Pasquale
    Salvi, Flavia
    Sanpaolo, Grazia
    Balleari, Enrico
    Germing, Ulrich
    Fenaux, Pierre
    Stamatoullas, Aspasia
    Palumbo, Giuseppe A.
    Salutari, Prassede
    Impera, Stefana
    Avanzini, Paolo
    Cortelezzi, Agostino
    Liberati, Anna Marina
    Carluccio, Paola
    Buccisano, Francesco
    Voso, Maria Teresa
    Mancini, Stefano
    Kulasekararaj, Austin
    Morabito, Fortunato
    Bocchia, Monica
    Cufari, Patrizia
    Spiriti, Maria Antonietta Aloe
    Santacaterina, Irene
    D'Errigo, Maria Grazia
    Bova, Irene
    Zini, Gina
    Latagliata, Roberto
    [J]. LANCET HAEMATOLOGY, 2017, 4 (03): : E127 - E136
  • [3] Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS)
    Oliva, Esther Natalie
    Riva, Marta
    Niscola, Pasquale
    Santini, Valeria
    Breccia, Massimo
    Giai, Valentina
    Poloni, Antonella
    Patriarca, Andrea
    Crisa, Elena
    Capodanno, Isabella
    Salutari, Prassede
    Reda, Gianluigi
    Cascavilla, Nicola
    Ferrero, Dario
    Guarini, Attilio
    Tripepi, Giovanni
    Ianni, Giuseppe
    Russo, Emilio
    Castelli, Andrea
    Fattizzo, Bruno
    Beltrami, Germana
    Bocchia, Monica
    Molteni, Alfredo
    Fenaux, Pierre
    Germing, Ulrich
    Ricco, Alessandra
    Palumbo, Giuseppe A.
    Impera, Stefana
    Di Renzo, Nicola
    Rivellini, Flavia
    Buccisano, Francesco
    Stamatoullas-Bastard, Aspasia
    Liberati, Anna Marina
    Candoni, Anna
    Delfino, Ilaria Maria
    Arcadi, Maria Teresa
    Cufari, Patrizia
    Rizzo, Lorenzo
    Bova, Irene
    D'Errigo, Maria Grazia
    Zini, Gina
    Latagliata, Roberto
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (28) : 4486 - +
  • [4] Efficacy of Low Power Laser Therapy in Fibromyalgia: A Single-blind, Placebo-controlled Trial
    A. Gür
    M. Karakoç
    K. Nas
    R. Çevik
    J. Saraç
    E. Demir
    [J]. Lasers in Medical Science, 2002, 17 : 57 - 61
  • [5] Efficacy of low power laser therapy in fibromyalgia:: A single-blind, placebo-controlled trial
    Gür, A
    Karakoç, M
    Nas, K
    Çevik, R
    Saraç, J
    Demir, E
    [J]. LASERS IN MEDICAL SCIENCE, 2002, 17 (01) : 57 - 61
  • [6] A PHASE 3 RANDOMIZED PLACEBO (PBO)-CONTROLLED DOUBLE-BLIND TRIAL OF DARBEPOETIN ALFA IN LOW OR INTERMEDIATE-1 (INT-1) RISK MYELODYSPLASTIC SYNDROMES (MDS)
    Platzbecker, U.
    Symeonidis, A.
    Oliva, E.
    Goede, J.
    Delforge, M.
    Mayer, J.
    Slama, B.
    Badre, S.
    Gasal, E.
    Mehta, B.
    Franklin, J.
    [J]. HAEMATOLOGICA, 2017, 102 : 484 - 484
  • [7] A PHASE 3 RANDOMIZED PLACEBO (PBO)-CONTROLLED DOUBLE-BLIND TRIAL OF DARBEPOETIN ALFA IN LOW OR INTERMEDIATE-1 (INT-1) RISK MYELODYSPLASTIC SYNDROMES (MDS)
    Platzbecker, U.
    Symeonidis, A.
    Oliva, E.
    Goede, J.
    Delforge, M.
    Mayer, J.
    Slama, B.
    Badre, S.
    Gasal, E.
    Mehta, B.
    Franklin, J.
    [J]. LEUKEMIA RESEARCH, 2017, 55 : S29 - S30
  • [8] Randomised Long Term Effects of Eltrombopag Treatment Versus Placebo for Low-Risk Myelodysplastic Syndromes with Thrombocytopenia (EQoL-MDS): Interim Results of a Single-Blind, Randomised, Controlled, Phase 2 Superiority Trial
    Oliva, Esther Natalie
    Alati, Caterina
    Santini, Valeria
    Poloni, Antonella
    Riva, Marta
    Niscola, Pasquale
    Giai, Valentina
    Sanpaolo, Grazia
    Balleari, Enrico
    Crisa, Elena
    Ferrero, Dario
    Germing, Ulrich
    Fenaux, Pierre
    Palumbo, Giuseppe A.
    Salutari, Prassede
    Impera, Stefana
    Capodanno, Isabella
    Reda, Gianluigi
    Liberati, Anna Marina
    Molteni, Alfredo
    Specchia, Giorgina
    Buccisano, Francesco
    Voso, Maria Teresa
    Mancini, Stefano
    Bocchia, Monica
    Candoni, Anna
    Martino, Bruno
    Cufari, Patrizia
    D'Errigo, Maria Grazia
    Zini, Gina
    Latagliata, Roberto
    [J]. BLOOD, 2019, 134
  • [9] Eltrombopag for Post-Transplantation Thrombocytopenia: Results of Phase II Randomized, Double-Blind, Placebo-Controlled Trial
    Ahmed, Sairah
    Bashir, Qaiser
    Bassett, Roland
    Poon, Man-Yin C.
    Valdez, Ben
    Konoplev, Sergej
    Alousi, Amin M.
    Andersson, Borje S.
    Ciurea, Stefan
    Hosing, Chitra
    Jones, Roy
    Kebriaei, Partow
    Khouri, Issa
    Kim, Stella
    Nieto, Yago
    Olson, Amanda
    Oran, Betul
    Parmar, Simrit
    Qazilbash, Muzaffar H.
    Rezvani, Katyoun
    Shah, Nina
    Shpall, E. J.
    Champlin, Richard
    Popat, Uday
    [J]. TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (05): : 430.e1 - 430.e7
  • [10] A Phase 3 Randomized Placebo (PBO)-Controlled Double-Blind Trial of Darbepoetin Alfa in the Treatment of Anemia in Patients with Low or Intermediate-1 (Int-1) Risk Myelodysplastic Syndromes (MDS)
    Platzbecker, Uwe
    Symeonidis, Argiris
    Oliva, Esther N.
    Goede, Jeroen S.
    Delforge, Michel
    Mayer, Jiri
    Slama, Borhane
    Badre, Sejal
    Gasal, Eduard
    Mehta, Bhakti
    Franklin, Janet
    [J]. BLOOD, 2016, 128 (22)